Nath Bio-Genes (India) per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹18.43₹20.98₹20.14₹21.34₹18.42
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹18.43₹20.98₹20.14₹21.34₹18.42
₹358.06₹358.06₹339.08₹320.94₹301.61
₹257.74₹234.21₹192.02₹175.03₹158.58
—−₹6.62₹9.25₹36.98₹20.19
−₹8.20−₹8.20₹5.08₹32.57₹18.85
—₹2.00₹2.00₹2.00₹2.00
1.91.91.91.91.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NATHBIOGEN₹132.38

Nath Bio-Genes (India) Limited

· FMCG & Retail
₹ CrorePeersSARVESHWARINDOUSSUKHJITSKOHINOORAGRITECHREGAALBSHSLGULPOLYMcap ₹252 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS18.4221.3420.1420.9818.43
Diluted EPS18.4221.3420.1420.9818.43
Book Value per Share301.61320.94339.08358.06358.06
Revenue per Share158.58175.03192.02234.21257.74
Cash Flow per Share20.1936.989.25-6.62—
Free Cash Flow per Share18.8532.575.08-8.20-8.20
Dividends per Share2.002.002.002.00—
Shares Outstanding (cr)1.91.91.91.91.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.